2022 Q1 Form 10-Q Financial Statement

#000165495422006755 Filed on May 13, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1 2020 Q3
Revenue $9.629M $11.80M $11.70M
YoY Change -18.39% 25.53% 34.72%
Cost Of Revenue $3.187M $3.643M $5.334M
YoY Change -12.53% 33.35% 50.18%
Gross Profit $6.442M $8.155M $6.366M
YoY Change -21.01% 22.33% 24.02%
Gross Profit Margin 66.91% 69.12% 54.41%
Selling, General & Admin $20.72M $10.99M $10.90M
YoY Change 88.48% -8.24% 1372.97%
% of Gross Profit 321.6% 134.79% 171.23%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $323.3K $240.5K $221.4K
YoY Change 34.42% 38.06% 1168.6%
% of Gross Profit 5.02% 2.95% 3.48%
Operating Expenses $11.45M $12.32M $10.90M
YoY Change -7.06% 0.45% 6.89%
Operating Profit -$5.010M -$4.168M -$4.531M
YoY Change 20.22% -25.59% -10.48%
Interest Expense -$38.67K -$7.750K -$32.49K
YoY Change 398.97% -55.82% -102.03%
% of Operating Profit
Other Income/Expense, Net $72.99K
YoY Change
Pretax Income -$4.657M -$13.05M -$5.364M
YoY Change -64.3% -187.66% -130.22%
Income Tax $0.00 -$536.0K $895.0K
% Of Pretax Income
Net Earnings -$4.657M -$12.51M -$6.259M
YoY Change -62.77% -184.05% -156.02%
Net Earnings / Revenue -48.37% -106.03% -53.49%
Basic Earnings Per Share -$0.10 -$0.24
Diluted Earnings Per Share -$0.10 -$0.24 -$119.6K
COMMON SHARES
Basic Shares Outstanding 58.97M shares 53.47M shares
Diluted Shares Outstanding 58.97M shares 53.47M shares

Balance Sheet

Concept 2022 Q1 2021 Q1 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.34M $24.74M $15.10M
YoY Change -42.06% 65.85% 175.14%
Cash & Equivalents $13.34M $23.71M $14.82M
Short-Term Investments $1.000M $1.032M $276.5K
Other Short-Term Assets $3.232M $3.823M $3.096M
YoY Change -15.46% 55.92% -19.53%
Inventory $5.232M $4.332M $4.892M
Prepaid Expenses
Receivables $2.046M $1.848M $911.5K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $24.33M $34.75M $23.71M
YoY Change -29.99% 39.63% 50.62%
LONG-TERM ASSETS
Property, Plant & Equipment $2.335M $9.217M $3.183M
YoY Change -74.67% -13.36% 85.57%
Goodwill $42.77M $54.67M
YoY Change
Intangibles $18.39M $21.64M
YoY Change
Long-Term Investments
YoY Change
Other Assets $138.7K $789.6K $790.7K
YoY Change -82.43% 4.53% 4.8%
Total Long-Term Assets $68.66M $86.31M $87.13M
YoY Change -20.45% -1.58% 10.61%
TOTAL ASSETS
Total Short-Term Assets $24.33M $34.75M $23.71M
Total Long-Term Assets $68.66M $86.31M $87.13M
Total Assets $92.99M $121.1M $110.8M
YoY Change -23.19% 7.53% 17.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.747M $2.835M $2.850M
YoY Change -3.12% -19.15% -5.65%
Accrued Expenses $2.977M $2.943M $3.884M
YoY Change 1.13% 38.72% 470.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $61.48K $1.085M $909.6K
YoY Change -94.33% 562.11%
Total Short-Term Liabilities $5.785M $6.864M $7.689M
YoY Change -15.71% 18.49% 107.26%
LONG-TERM LIABILITIES
Long-Term Debt $77.73K $567.9K $264.4K
YoY Change -86.31% 176.05%
Other Long-Term Liabilities $7.102M $27.71M $22.47M
YoY Change -74.38% 92.1% -55.9%
Total Long-Term Liabilities $7.179M $28.28M $23.97M
YoY Change -74.62% 93.28% -52.96%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.785M $6.864M $7.689M
Total Long-Term Liabilities $7.179M $28.28M $23.97M
Total Liabilities $12.96M $35.17M $31.66M
YoY Change -63.14% 72.2% -44.37%
SHAREHOLDERS EQUITY
Retained Earnings -$99.16M -$47.39M
YoY Change
Common Stock $59.35K $52.13K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $80.02M $85.88M $79.18M
YoY Change
Total Liabilities & Shareholders Equity $92.99M $121.1M $110.8M
YoY Change -23.19% 7.53% 17.27%

Cashflow Statement

Concept 2022 Q1 2021 Q1 2020 Q3
OPERATING ACTIVITIES
Net Income -$4.657M -$12.51M -$6.259M
YoY Change -62.77% -184.05% -156.02%
Depreciation, Depletion And Amortization $323.3K $240.5K $221.4K
YoY Change 34.42% 38.06% 1168.6%
Cash From Operating Activities -$5.202M -$2.959M -$387.3K
YoY Change 75.81% -30.76% -93.87%
INVESTING ACTIVITIES
Capital Expenditures -$142.8K -$133.2K $531.7K
YoY Change 7.14% -89.26% -165.7%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$1.290M -$250.0K
YoY Change -100.0% -188.63%
Cash From Investing Activities -$142.8K -$1.423M $281.6K
YoY Change -89.97% 14.72% -153.43%
FINANCING ACTIVITIES
Cash Dividend Paid $1.001M
YoY Change
Common Stock Issuance & Retirement, Net $22.30M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.015M -670.0K -76.07K
YoY Change 51.53% -104.01% -19.03%
NET CHANGE
Cash From Operating Activities -5.202M -2.959M -387.3K
Cash From Investing Activities -142.8K -1.423M 281.6K
Cash From Financing Activities -1.015M -670.0K -76.07K
Net Change In Cash -6.360M -5.052M -181.7K
YoY Change 25.89% -145.21% -97.38%
FREE CASH FLOW
Cash From Operating Activities -$5.202M -$2.959M -$387.3K
Capital Expenditures -$142.8K -$133.2K $531.7K
Free Cash Flow -$5.059M -$2.826M -$918.9K
YoY Change 79.04% -6.83% -83.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
59357213 shares
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13336850 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26411424 USD
CY2022Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2045602 USD
CY2021Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1113372 USD
CY2022Q1 us-gaap Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net
DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
1375 USD
CY2021Q3 us-gaap Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net
DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
10967 USD
CY2022Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0 USD
CY2021Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
33351 USD
CY2022Q1 us-gaap Other Investments And Securities At Cost
OtherInvestmentsAndSecuritiesAtCost
1000000 USD
CY2021Q3 us-gaap Other Investments And Securities At Cost
OtherInvestmentsAndSecuritiesAtCost
1000000 USD
CY2022Q1 us-gaap Inventory Gross
InventoryGross
4713041 USD
CY2021Q3 us-gaap Inventory Gross
InventoryGross
5021867 USD
CY2022Q1 ycbd Prepaid Inventory Current
PrepaidInventoryCurrent
519128 USD
CY2021Q3 ycbd Prepaid Inventory Current
PrepaidInventoryCurrent
551519 USD
CY2022Q1 ycbd Prepaid Sponsorship
PrepaidSponsorship
1474350 USD
CY2021Q3 ycbd Prepaid Sponsorship
PrepaidSponsorship
1212682 USD
CY2022Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1236744 USD
CY2021Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1147178 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
24327090 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
36502360 USD
CY2021Q1 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Diluted
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
-13070754 USD
us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Diluted
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
-25819122 USD
us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Diluted
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
-22566426 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2334619 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2561574 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5025669 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5614960 USD
CY2022Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
138708 USD
CY2021Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
529583 USD
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18389258 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23003929 USD
CY2022Q1 us-gaap Goodwill
Goodwill
42772685 USD
CY2021Q3 us-gaap Goodwill
Goodwill
56670970 USD
CY2022Q1 us-gaap Other Assets
OtherAssets
68660939 USD
CY2021Q3 us-gaap Other Assets
OtherAssets
88381016 USD
CY2022Q1 us-gaap Assets
Assets
92988029 USD
CY2021Q3 us-gaap Assets
Assets
124883376 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2746837 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2978914 USD
CY2022Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1840797 USD
CY2021Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2727612 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1136018 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1151150 USD
CY2022Q1 us-gaap Notes Payable Current
NotesPayableCurrent
61483 USD
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
59470 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5785135 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6917146 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
77732 USD
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
108985 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4278733 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4859058 USD
CY2022Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
2823000 USD
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
9856000 USD
CY2022Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
7179465 USD
CY2021Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
14824043 USD
CY2022Q1 us-gaap Liabilities
Liabilities
12964600 USD
CY2021Q3 us-gaap Liabilities
Liabilities
21741189 USD
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5000000 shares
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
5000 USD
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
5000 USD
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59352213 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57783340 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
59352 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
57783 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
179116064 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
176417269 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-99156987 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73337865 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
80023429 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
103142187 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
92988029 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
545562 USD
CY2022Q1 ycbd Decrease Increase Of Contingent Liability
DecreaseIncreaseOfContingentLiability
353000 USD
CY2021Q1 ycbd Decrease Increase Of Contingent Liability
DecreaseIncreaseOfContingentLiability
-8871000 USD
ycbd Decrease Increase Of Contingent Liability
DecreaseIncreaseOfContingentLiability
6303000 USD
ycbd Decrease Increase Of Contingent Liability
DecreaseIncreaseOfContingentLiability
-17371000 USD
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2249 USD
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
72987 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
124883376 USD
CY2022Q1 ycbd Sales Revenue Gross
SalesRevenueGross
9948858 USD
CY2021Q1 ycbd Sales Revenue Gross
SalesRevenueGross
12457386 USD
ycbd Sales Revenue Gross
SalesRevenueGross
19805625 USD
ycbd Sales Revenue Gross
SalesRevenueGross
25520568 USD
CY2022Q1 ycbd Sales Allowances
SalesAllowances
319972 USD
CY2021Q1 ycbd Sales Allowances
SalesAllowances
658775 USD
ycbd Sales Allowances
SalesAllowances
854917 USD
ycbd Sales Allowances
SalesAllowances
1393654 USD
CY2022Q1 us-gaap Revenues
Revenues
9628886 USD
CY2021Q1 us-gaap Revenues
Revenues
11798611 USD
us-gaap Revenues
Revenues
18950708 USD
us-gaap Revenues
Revenues
24126914 USD
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
3186564 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
3643127 USD
us-gaap Cost Of Revenue
CostOfRevenue
7514874 USD
us-gaap Cost Of Revenue
CostOfRevenue
7073402 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
6442322 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
8155484 USD
us-gaap Gross Profit
GrossProfit
11435834 USD
us-gaap Gross Profit
GrossProfit
17053512 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
11452700 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
12323207 USD
us-gaap Operating Expenses
OperatingExpenses
23407984 USD
us-gaap Operating Expenses
OperatingExpenses
22981180 USD
CY2022Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2021Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
18183285 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5010378 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4167723 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-30155435 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5927668 USD
CY2022Q1 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
CY2021Q1 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
2852 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-33352 USD
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2086 USD
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-10603 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-5320 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-20990 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4657215 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13046474 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23818120 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22774096 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-536000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-868000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4657215 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-12510474 USD
us-gaap Net Income Loss
NetIncomeLoss
-23818120 USD
us-gaap Net Income Loss
NetIncomeLoss
-21906096 USD
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1000500 USD
CY2021Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
560280 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2001002 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
660330 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5657715 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13070754 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25819122 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-22566426 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.43
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.43
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58966979 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53471607 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59073963 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52793872 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58966979 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53471607 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59073963 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52793872 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4657215 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-12510474 USD
us-gaap Net Income Loss
NetIncomeLoss
-23818120 USD
us-gaap Net Income Loss
NetIncomeLoss
-21906096 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4657215 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12510474 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23818120 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21906096 USD
CY2022Q1 ycbd Dividend Preferred
DividendPreferred
-1000500 USD
CY2021Q1 ycbd Dividend Preferred
DividendPreferred
-560280 USD
ycbd Dividend Preferred
DividendPreferred
-2001002 USD
ycbd Dividend Preferred
DividendPreferred
-660330 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5657715 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-13070754 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-25819122 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-22566426 USD
us-gaap Profit Loss
ProfitLoss
23818120 USD
us-gaap Profit Loss
ProfitLoss
21906096 USD
us-gaap Share Based Compensation
ShareBasedCompensation
797096 USD
us-gaap Share Based Compensation
ShareBasedCompensation
451527 USD
us-gaap Restricted Stock Expense
RestrictedStockExpense
837267 USD
us-gaap Restricted Stock Expense
RestrictedStockExpense
547140 USD
ycbd Marketing Stock Amortization
MarketingStockAmortization
-339520 USD
ycbd Marketing Stock Amortization
MarketingStockAmortization
0 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
155695 USD
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
878142 USD
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
0 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
329671 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
600750 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
473324 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
18183285 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
ycbd Increase Decrease In Contingent Liability
IncreaseDecreaseInContingentLiability
-6303000 USD
ycbd Increase Decrease In Contingent Liability
IncreaseDecreaseInContingentLiability
17371000 USD
ycbd Realized And Unrealized Loss Of Marketable And Other Securities
RealizedAndUnrealizedLossOfMarketableAndOtherSecurities
-33350 USD
ycbd Realized And Unrealized Loss Of Marketable And Other Securities
RealizedAndUnrealizedLossOfMarketableAndOtherSecurities
5562 USD
us-gaap Severance Costs1
SeveranceCosts1
0 USD
us-gaap Severance Costs1
SeveranceCosts1
352279 USD
us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
589291 USD
us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
611298 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
932230 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
936983 USD
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
390875 USD
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
1125 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
569316 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-271815 USD
ycbd Increase Decrease In Prepaid Inventory
IncreaseDecreaseInPrepaidInventory
-32391 USD
ycbd Increase Decrease In Prepaid Inventory
IncreaseDecreaseInPrepaidInventory
190451 USD
ycbd Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
354752 USD
ycbd Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
44408 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1129614 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1366373 USD
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-595457 USD
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-540664 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
10723 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-41418 USD
ycbd Collection On Discontinued Operations Accounts Receivable
CollectionOnDiscontinuedOperationsAccountsReceivable
9592 USD
ycbd Collection On Discontinued Operations Accounts Receivable
CollectionOnDiscontinuedOperationsAccountsReceivable
424917 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
868000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10670537 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5151019 USD
ycbd Proceeds From Sale Of Other Investment Securities
ProceedsFromSaleOfOtherInvestmentSecurities
0 USD
ycbd Proceeds From Sale Of Other Investment Securities
ProceedsFromSaleOfOtherInvestmentSecurities
750000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
373795 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
226542 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-373795 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-976542 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
15798115 USD
us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
-29240 USD
us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
-123268 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
2001002 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
660330 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2030242 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15014517 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-13074574 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
8886956 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26411424 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14824644 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13336850 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23711600 USD
us-gaap Interest Paid Net
InterestPaidNet
4173 USD
us-gaap Interest Paid Net
InterestPaidNet
7117 USD
ycbd Issuance Of Contingent Earnout Shares
IssuanceOfContingentEarnoutShares
730000 USD
ycbd Issuance Of Contingent Earnout Shares
IssuanceOfContingentEarnoutShares
11271000 USD
ycbd Warrants Issued To Representative
WarrantsIssuedToRepresentative
0 USD
ycbd Warrants Issued To Representative
WarrantsIssuedToRepresentative
254950 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
103142187 USD
CY2021Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
405000 USD
CY2021Q4 ycbd Issuance Of Options For Share Based Compensation
IssuanceOfOptionsForShareBasedCompensation
505466 USD
CY2021Q4 ycbd Issuance Of Restricted Stock For Share Based Compensation
IssuanceOfRestrictedStockForShareBasedCompensation
508754 USD
CY2021Q4 ycbd Preferred Dividend
PreferredDividend
-1000502 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-19160904 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
84400000 USD
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
661000 USD
CY2022Q1 ycbd Issuance Of Options For Share Based Compensation
IssuanceOfOptionsForShareBasedCompensation
291630 USD
CY2022Q1 ycbd Issuance Of Restricted Stock For Share Based Compensation
IssuanceOfRestrictedStockForShareBasedCompensation
328515 USD
CY2022Q1 ycbd Preferred Dividend
PreferredDividend
-1000500 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4657215 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
80023429 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
79182048 USD
CY2020Q4 ycbd Preferred Stock Issued During Period Value New Issues
PreferredStockIssuedDuringPeriodValueNewIssues
15795815 USD
CY2020Q4 ycbd Issuance Of Options For Share Based Compensation
IssuanceOfOptionsForShareBasedCompensation
219875 USD
CY2020Q4 ycbd Issuance Of Restricted Stock For Share Based Compensation
IssuanceOfRestrictedStockForShareBasedCompensation
15279 USD
CY2020Q4 ycbd Preferred Dividend
PreferredDividend
-100050 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-9395621 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
85719646 USD
CY2021Q1 ycbd Preferred Stock Issued During Period Value New Issues
PreferredStockIssuedDuringPeriodValueNewIssues
15795815 USD
CY2021Q1 ycbd Exercise Of Options For Share Based Compensation Amount
ExerciseOfOptionsForShareBasedCompensationAmount
627648 USD
CY2021Q1 ycbd Issuance Of Restricted Stock For Share Based Compensationamount
IssuanceOfRestrictedStockForShareBasedCompensationamount
1181828 USD
CY2021Q1 ycbd Preferred Dividend
PreferredDividend
-560279 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-12510474 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
85884569 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
19215 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3633 USD
ycbd Merchant Receivable And Reservepolicytextblock
MerchantReceivableAndReservepolicytextblock
The Company primarily sells its products through the internet and has an arrangement to process customer payments with third-party payment processors and negotiate the fee based on the market. The arrangement with the payment processors requires that the Company pay a fee between 2.6% and 5.0% of the transaction amounts processed. Pursuant to this agreement, there can be a waiting period between 2 to 5 days prior to reimbursement to the Company, as well as a calculated reserve which some payment processors hold back. Fees and reserves can change periodically with notice from the processors. At March 31, 2022, the receivable from payment processors included approximately $264,305 for the waiting period amount and is recorded as accounts receivable in the accompanying condensed consolidated balance sheet.
ycbd Receivable From Payment Processors
ReceivableFromPaymentProcessors
264305 USD
CY2020 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
1456100 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1466113 USD
CY2022Q1 us-gaap Revenues
Revenues
9628886 USD
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.000 pure
CY2021Q1 us-gaap Revenues
Revenues
11798611 USD
CY2021Q1 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.000 pure
us-gaap Revenues
Revenues
18950708 USD
CY2022Q1 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.000 pure
us-gaap Revenues
Revenues
24126914 USD
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.000 pure
CY2022Q1 us-gaap Inventory Net
InventoryNet
5232169 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable, and securities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company places its cash and cash equivalents on deposit with financial institutions in the United States. The Federal Deposit Insurance Corporation (“FDIC”) covers $250,000 for substantially all depository accounts. The Company from time to time may have amounts on deposit in excess of the insured limits. The Company had a $12,621,509 uninsured balance at March 31, 2022 and a $23,508,953 uninsured balance at September 30, 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Concentration of credit risk with respect to receivables is principally limited to trade receivables with corporate customers that meet specific credit policies. Management considers these customer receivables to represent normal business risk. The Company did not have any customers that represented a significant amount of our sales for the three and six months ended March 31, 2022.</p>
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000 USD
CY2022Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
12621509 USD
CY2021Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
23508953 USD
CY2021Q1 ycbd Marketable Securities Realized Gain Loss1
MarketableSecuritiesRealizedGainLoss1
2852 USD
ycbd Marketable Securities Realized Gain Loss1
MarketableSecuritiesRealizedGainLoss1
-33350 USD
ycbd Marketable Securities Realized Gain Loss1
MarketableSecuritiesRealizedGainLoss1
545562 USD
CY2022Q1 ycbd Total Acquisition Shares
TotalAcquisitionShares
1042193 shares
CY2022Q1 us-gaap Alternative Investment
AlternativeInvestment
1000000 USD
CY2021Q3 ycbd Other Investments And Securities
OtherInvestmentsAndSecurities
1033351 USD
CY2021Q4 ycbd Change In Value Of Equities
ChangeInValueOfEquities
-33351 USD
CY2021Q4 ycbd Additional Investment
AdditionalInvestment
0 USD
CY2021Q4 ycbd Other Investments And Securities
OtherInvestmentsAndSecurities
1000000 USD
CY2022Q1 ycbd Change In Value Of Equities
ChangeInValueOfEquities
0 USD
CY2022Q1 ycbd Additional Investment
AdditionalInvestment
0 USD
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3309847 USD
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3362897 USD
CY2022Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1509798 USD
CY2021Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1729176 USD
CY2022Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
106604 USD
CY2021Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
70206 USD
CY2022Q1 ycbd Inventory Prepaid
InventoryPrepaid
519128 USD
CY2021Q3 ycbd Inventory Prepaid
InventoryPrepaid
551519 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
5573386 USD
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2475553 USD
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1863774 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2334619 USD
CY2021 ycbd Issuance Two Tranches Shares
IssuanceTwoTranchesShares
6500000 shares
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2561574 USD
CY2022Q1 us-gaap Depreciation
Depreciation
323294 USD
CY2021Q1 us-gaap Depreciation
Depreciation
240517 USD
us-gaap Depreciation
Depreciation
611780 USD
us-gaap Depreciation
Depreciation
473323 USD
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4810173 USD
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4425348 USD
CY2021Q3 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P10Y
CY2022Q1 ycbd Amortization Of Definite Lived Intangible Assets
AmortizationOfDefiniteLivedIntangibleAssets
-378153 USD
CY2021Q3 ycbd Amortization Of Definite Lived Intangible Assets
AmortizationOfDefiniteLivedIntangibleAssets
-48482 USD
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18389258 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23003929 USD
CY2021 ycbd Additional Shares
AdditionalShares
15250000 shares
CY2021 ycbd Devlopment Issuance Of Two Tranches
DevlopmentIssuanceOfTwoTranches
15250000 shares
CY2021 ycbd Initial Shares Issued Shares
InitialSharesIssuedShares
15250000 shares
CY2021 ycbd Initial Shares Issued Value
InitialSharesIssuedValue
53215163 USD
CY2020Q1 ycbd Earnout Shares Issued
EarnoutSharesIssued
5127792 shares
CY2021Q1 ycbd Earnout Shares Issued
EarnoutSharesIssued
3348520 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0.001
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q2 ycbd Earnout Shares Issued
EarnoutSharesIssued
562278 shares
CY2021 ycbd Deceased In Share Value
DeceasedInShareValue
522104 USD
CY2021Q2 ycbd Earnout Shares Issued
EarnoutSharesIssued
503275 shares
ycbd Deceased In Share Value
DeceasedInShareValue
222442 USD
CY2021Q2 ycbd Business Combination Contingent Consideration Liability Noncurrent Liability
BusinessCombinationContingentConsiderationLiabilityNoncurrentLiability
920000 USD
CY2022Q1 us-gaap Shares Issued
SharesIssued
466713 shares
ycbd Decrease In Additional Shares
DecreaseInAdditionalShares
366841 shares
ycbd Initial Shares Issued Value
InitialSharesIssuedValue
405000 USD
ycbd Additional Earnout Shares
AdditionalEarnoutShares
444243000000 shares
ycbd Shares Increased In Value
SharesIncreasedInValue
41914000000 USD
ycbd Contingent Liability To Additional Paid In Capital
ContingentLiabilityToAdditionalPaidInCapital
325000000000 USD
CY2022Q1 ycbd Business Combination Contingent Consideration Liability Noncurrent Liability
BusinessCombinationContingentConsiderationLiabilityNoncurrentLiability
2810000 USD
CY2021Q3 ycbd Business Combination Contingent Consideration Liability Noncurrent Liability
BusinessCombinationContingentConsiderationLiabilityNoncurrentLiability
9440000 USD
CY2021Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
200000 shares
CY2021Q3 ycbd Business Combination Contingent Consideration Liability Noncurrent Liability
BusinessCombinationContingentConsiderationLiabilityNoncurrentLiability
488561 USD
CY2021Q3 ycbd Increase Of Contingent Liability
IncreaseOfContingentLiability
73561 USD
CY2021Q3 ycbd Earnout Shares Amount
EarnoutSharesAmount
416000 USD
CY2022Q1 ycbd Decrease In Value Of The Contingent Liability
DecreaseInValueOfTheContingentLiability
255000 USD
CY2021Q3 ycbd Increases Second Market Value
IncreasesSecondMarketValue
161000 USD
CY2021Q4 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
120000 shares
CY2021Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
8000000 shares
CY2021Q4 ycbd Net Sales
NetSales
3000000 USD
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2022Q1 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59352213 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57783340 shares
CY2021Q1 ycbd Restricted Common Stock
RestrictedCommonStock
27000 shares
CY2021Q1 ycbd Restricted Common Stock Amount
RestrictedCommonStockAmount
118800 USD
CY2022Q1 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
57000 USD
CY2015Q2 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
1175000 shares
ycbd Increase In Shares Of Common Stock
IncreaseInSharesOfCommonStock
100000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
2000000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
5000000 shares
us-gaap Payments For Restructuring
PaymentsForRestructuring
2867000 USD
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1400000 shares
CY2021 us-gaap Payments For Restructuring
PaymentsForRestructuring
800000 USD
us-gaap Payments For Fees
PaymentsForFees
100000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
667000 USD
us-gaap Payments For Fees
PaymentsForFees
40000 USD
us-gaap Payments For Fees
PaymentsForFees
50000 USD
us-gaap Payments For Fees
PaymentsForFees
75000 USD
us-gaap Payments For Fees
PaymentsForFees
85000 USD
CY2021Q1 ycbd Total Number Of Shares Issued And Outstanding
TotalNumberOfSharesIssuedAndOutstanding
250000 shares
ycbd Unrecognized Compensation
UnrecognizedCompensation
897788 USD
ycbd Description Of Non Vested Option
DescriptionOfNonVestedOption
non-vested stock options which vest over a period of approximately 2.8 years
CY2022Q1 ycbd Restricted Common Stock Shares
RestrictedCommonStockShares
30000 shares
CY2022Q1 ycbd Restricted Common Stock Amount
RestrictedCommonStockAmount
29250 USD
CY2021Q4 ycbd Restricted Common Stock Shares
RestrictedCommonStockShares
120000 shares
CY2021Q4 ycbd Restricted Common Stock Shares
RestrictedCommonStockShares
5000 shares
CY2021Q1 ycbd Restricted Common Stock Shares
RestrictedCommonStockShares
167500 shares
CY2021Q1 ycbd Restricted Common Stock Amount
RestrictedCommonStockAmount
494125 USD
CY2022Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
328515 USD
CY2021Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
531605 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
660417 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.60
CY2019 us-gaap Payments For Restructuring
PaymentsForRestructuring
4900000 USD
CY2021Q4 ycbd Recorded Expense
RecordedExpense
422309 USD
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0466 pure
CY2020Q4 ycbd Recorded Expense
RecordedExpense
253700 USD
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
320000 shares
us-gaap Increase Decrease In Other Loans
IncreaseDecreaseInOtherLoans
249100 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
70357 USD
ycbd Monthly Payment Period
MonthlyPaymentPeriod
P60Y
ycbd Financing Rate
FinancingRate
0.0701 pure
us-gaap Sale Leaseback Transaction Monthly Rental Payments
SaleLeasebackTransactionMonthlyRentalPayments
4905 USD
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
386783 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
773564 USD
CY2022Q1 us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
392029 USD
us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
782256 USD
ycbd Weighted Average Remaining Lease Term Operating Leases
WeightedAverageRemainingLeaseTermOperatingLeases
P4Y4M17D
CY2022Q1 ycbd Net Loss Income From Continuing Operation
NetLossIncomeFromContinuingOperation
-4657215 USD
CY2021Q1 ycbd Net Loss Income From Continuing Operation
NetLossIncomeFromContinuingOperation
-12510474 USD
ycbd Net Loss Income From Continuing Operation
NetLossIncomeFromContinuingOperation
-23818120 USD
ycbd Net Loss Income From Continuing Operation
NetLossIncomeFromContinuingOperation
-21906096 USD
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1000500 USD
CY2021Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
560280 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2001002 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
660330 USD
CY2022Q1 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Diluted
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
-5657715 USD
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2022Q1 ycbd Net Income Loss From Continuing And Discontinued Operations Available To Common Stockholders Basic
NetIncomeLossFromContinuingAndDiscontinuedOperationsAvailableToCommonStockholdersBasic
-5657715 USD
CY2021Q1 ycbd Net Income Loss From Continuing And Discontinued Operations Available To Common Stockholders Basic
NetIncomeLossFromContinuingAndDiscontinuedOperationsAvailableToCommonStockholdersBasic
-13070754 USD
ycbd Net Income Loss From Continuing And Discontinued Operations Available To Common Stockholders Basic
NetIncomeLossFromContinuingAndDiscontinuedOperationsAvailableToCommonStockholdersBasic
-25819122 USD
ycbd Net Income Loss From Continuing And Discontinued Operations Available To Common Stockholders Basic
NetIncomeLossFromContinuingAndDiscontinuedOperationsAvailableToCommonStockholdersBasic
-22566426 USD
CY2022Q1 ycbd Diluted Net Income Loss
DilutedNetIncomeLoss
-5657715 USD
CY2021Q1 ycbd Diluted Net Income Loss
DilutedNetIncomeLoss
-13070754 USD
ycbd Diluted Net Income Loss
DilutedNetIncomeLoss
-25819122 USD
ycbd Diluted Net Income Loss
DilutedNetIncomeLoss
-22566426 USD
CY2022Q1 ycbd Shares Used In Computing Basic Earnings Per Shares
SharesUsedInComputingBasicEarningsPerShares
58966979 shares
CY2021Q1 ycbd Shares Used In Computing Basic Earnings Per Shares
SharesUsedInComputingBasicEarningsPerShares
53471607 shares
ycbd Shares Used In Computing Basic Earnings Per Shares
SharesUsedInComputingBasicEarningsPerShares
59073963 shares
ycbd Shares Used In Computing Basic Earnings Per Shares
SharesUsedInComputingBasicEarningsPerShares
52793872 shares
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.10
CY2021Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.24
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.44
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.43
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2021Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.43
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.10
CY2021Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.24
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.44
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.43
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2021Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.43
CY2019Q4 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.080 pure
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
4600000 USD

Files In Submission

Name View Source Status
0001654954-22-006755-index-headers.html Edgar Link pending
0001654954-22-006755-index.html Edgar Link pending
0001654954-22-006755.txt Edgar Link pending
0001654954-22-006755-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ycbd-20220331.xsd Edgar Link pending
ycbd-20220331_cal.xml Edgar Link unprocessable
ycbd-20220331_def.xml Edgar Link unprocessable
ycbd-20220331_lab.xml Edgar Link unprocessable
ycbd-20220331_pre.xml Edgar Link unprocessable
ycbd_10q.htm Edgar Link pending
ycbd_10qimg1.jpg Edgar Link pending
ycbd_10qimg2.jpg Edgar Link pending
ycbd_10qimg3.jpg Edgar Link pending
ycbd_10qimg4.jpg Edgar Link pending
ycbd_10qimg5.jpg Edgar Link pending
ycbd_10q_htm.xml Edgar Link completed
ycbd_ex1021.htm Edgar Link pending
ycbd_ex1021img10.jpg Edgar Link pending
ycbd_ex1021img11.jpg Edgar Link pending
ycbd_ex1021img12.jpg Edgar Link pending
ycbd_ex1021img13.jpg Edgar Link pending
ycbd_ex1021img14.jpg Edgar Link pending
ycbd_ex1021img15.jpg Edgar Link pending
ycbd_ex1021img8.jpg Edgar Link pending
ycbd_ex1021img9.jpg Edgar Link pending
ycbd_ex311.htm Edgar Link pending
ycbd_ex312.htm Edgar Link pending
ycbd_ex313.htm Edgar Link pending
ycbd_ex321.htm Edgar Link pending